Bank of New York Mellon Corp Boosts Stock Position in Definitive Healthcare Corp. (NASDAQ:DH)

Bank of New York Mellon Corp raised its position in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 35.9% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 229,143 shares of the company’s stock after buying an additional 60,559 shares during the period. Bank of New York Mellon Corp’s holdings in Definitive Healthcare were worth $942,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Massachusetts Financial Services Co. MA boosted its position in shares of Definitive Healthcare by 36.8% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock worth $27,058,000 after purchasing an additional 1,626,813 shares in the last quarter. State Street Corp raised its stake in Definitive Healthcare by 29.4% in the third quarter. State Street Corp now owns 1,399,729 shares of the company’s stock valued at $6,257,000 after buying an additional 317,952 shares during the last quarter. 272 Capital LP boosted its holdings in Definitive Healthcare by 74.8% in the third quarter. 272 Capital LP now owns 1,114,080 shares of the company’s stock worth $4,980,000 after acquiring an additional 476,766 shares in the last quarter. New York State Common Retirement Fund grew its stake in shares of Definitive Healthcare by 3.2% during the fourth quarter. New York State Common Retirement Fund now owns 771,792 shares of the company’s stock worth $3,172,000 after acquiring an additional 23,815 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Definitive Healthcare by 5.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 436,132 shares of the company’s stock worth $1,950,000 after acquiring an additional 23,706 shares during the last quarter. 98.67% of the stock is currently owned by institutional investors.

Definitive Healthcare Trading Down 2.0 %

NASDAQ DH opened at $2.91 on Wednesday. Definitive Healthcare Corp. has a 1 year low of $2.55 and a 1 year high of $8.35. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49. The company has a market capitalization of $328.57 million, a PE ratio of -0.94, a P/E/G ratio of 4.06 and a beta of 1.51. The company has a fifty day moving average of $4.16 and a 200 day moving average of $4.29.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings data on Thursday, February 27th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.04). Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. The company had revenue of $62.29 million during the quarter, compared to analyst estimates of $60.60 million. Research analysts forecast that Definitive Healthcare Corp. will post 0.16 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently commented on DH. The Goldman Sachs Group decreased their price objective on shares of Definitive Healthcare from $4.50 to $3.00 and set a “neutral” rating for the company in a research report on Tuesday, March 4th. Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a report on Thursday, January 16th. Stephens assumed coverage on shares of Definitive Healthcare in a report on Friday, December 20th. They set an “equal weight” rating and a $5.00 price objective on the stock. Finally, Barclays reduced their target price on Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating for the company in a research note on Monday, March 3rd. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $5.35.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.